HeterozygousHTRA1mutations are associated with autosomal dominant cerebral small vessel disease
Open Access
- 10 June 2015
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain
- Vol. 138 (8), 2347-2358
- https://doi.org/10.1093/brain/awv155
Abstract
Cerebral small vessel disease represents a heterogeneous group of disorders leading to stroke and cognitive impairment. While most small vessel diseases appear sporadic and related to age and hypertension, several early-onset monogenic forms have also been reported. However, only a minority of patients with familial small vessel disease carry mutations in one of known small vessel disease genes. We used whole exome sequencing to identify candidate genes in an autosomal dominant small vessel disease family in which known small vessel disease genes had been excluded, and subsequently screened all candidate genes in 201 unrelated probands with a familial small vessel disease of unknown aetiology, using high throughput multiplex polymerase chain reaction and next generation sequencing. A heterozygous HTRA1 variant (R166L), absent from 1000 Genomes and Exome Variant Server databases and predicted to be deleterious by in silico tools, was identified in all affected members of the index family. Ten probands of 201 additional unrelated and affected probands (4.97%) harboured a heterozygous HTRA1 mutation predicted to be damaging. There was a highly significant difference in the number of likely deleterious variants in cases compared to controls (P = 4.2 × 10−6; odds ratio = 15.4; 95% confidence interval = 4.9–45.5), strongly suggesting causality. Seven of these variants were located within or close to the HTRA1 protease domain, three were in the N-terminal domain of unknown function and one in the C-terminal PDZ domain. In vitro activity analysis of HTRA1 mutants demonstrated a loss of function effect. Clinical features of this autosomal dominant small vessel disease differ from those of CARASIL and CADASIL by a later age of onset and the absence of the typical extraneurological features of CARASIL. They are similar to those of sporadic small vessel disease, except for their familial nature. Our data demonstrate that heterozygous HTRA1 mutations are an important cause of familial small vessel disease, and that screening of HTRA1 should be considered in all patients with a hereditary small vessel disease of unknown aetiology.Keywords
This publication has 17 references indexed in Scilit:
- Cerebral small vessel disease-related protease HtrA1 processes latent TGF-β binding protein 1 and facilitates TGF-β signalingProceedings of the National Academy of Sciences of the United States of America, 2014
- Two novel HTRA1 mutations in a European CARASIL patientNeurology, 2014
- A novel mutation of the high-temperature requirement A serine peptidase 1 (HTRA1) gene in a Chinese family with cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL)Journal of International Medical Research, 2013
- Mutations in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormalitiesNature, 2012
- A missense HTRA1 mutation expands CARASIL syndrome to the Caucasian populationNeurology, 2010
- CADASILThe Lancet Neurology, 2009
- Association of HTRA1 Mutations and Familial Ischemic Cerebral Small-Vessel DiseaseThe New England Journal of Medicine, 2009
- Role of COL4A1 in Small-Vessel Disease and Hemorrhagic StrokeThe New England Journal of Medicine, 2006
- The HtrA Family of Proteases: Implications for Protein Composition and Cell FateMolecular Cell, 2002
- Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementiaNature, 1996